News

The International Conference on Microbiome-Gut-Brain Axis Is Back!

Read

Cerebiome® exerts a positive influence on the gut microbiota of individuals with mild anxiety, new study finds

Read

SYLVIE BINDA PRESENTS AT THE JOURNÉE MICROBIOTES ET SANTÉ

Read

SCIENTIFIC EXCHANGE 2023: A Journey to The Top; The Past, Present, and Future of Probiotics Applications in Human Wellbeing

Read

Lallemand, An Active Member of The Grand Défi Ferments Du Futur Consortium: Innovating For the Food of Tomorrow

Read

Sylvie Binda elected on the Pharmabiotic Research Institute board of directors

Read

Lallemand Health Solutions Appoints Vincent Thomas, Ph.D. as R&D Innovation Director

Read

Lallemand Health Solutions supports the innovative French Gut Project to accelerate microbiota science

Read

Lallemand Health Solutions Opens the SEMiPyP Congress With An Update on IBacilluS+: A Highly Documented Probiotic Formula for Serious Gut Conditions

Read

Having IMPACTT 2022: The Rosell® Institute for Microbiome and Probiotics Renews Its Platinum Sponsorship

Read